Inhaled Steroids Tied to Increased Pneumonia Risk in Asthma Patients
83% higher rate of pneumonia hospitalization
Inhaled corticosteroid use is a well recognized risk factor for pneumonia hospitalization in patients with COPD, and it may also increase pneumonia risk in patients with asthma.
Use of inhaled steroids was associated with an 83% increased risk of hospitalization for pneumonia among some 150,000 asthma teenage and young adult patients treated in Quebec, Canada, although the absolute risk remained very low.....
Read more here: medpagetoday.com
------------------------------------------------------
Many Students Reluctant to Use Asthma Inhalers at School
FRIDAY, April 21, 2017 (HealthDay News) -- The thought of having to pull out an inhaler in the middle of school might stop some kids with asthma from breathing better, a study of British schoolchildren suggests.
An online survey of almost 700 students with asthma showed that nearly 50 percent reported poor asthma control.
With asthma, the lungs and airways become inflamed when exposed to triggers that can include pollen, catching a cold or having a respiratory infection. Childhood asthma can interfere with play, sports, school and sleep. Unmanaged asthma can cause dangerous asthma attacks.....
Read more here: health.usnews.com
------------------------------------------------------
Teva's new asthma inhaler poses first competition for GSK's Advair
Teva Pharmaceutical Industries Ltd (TEVA.TA) (TEVA.N) on Thursday launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline's (GSK.L) best-selling Advair.
Teva, which won U.S. approval in January to make an inhaler similar to Advair, also launched a generic version of its own inhaler, AirDuo RespiClick.
AirDuo is not a true generic of Advair, but contains the same two active ingredients, fluticasone propionate and salmeterol. However, it delivers a lower dose of salmeterol and uses Teva's RespiClick inhaler rather than copying GSK's device.....
Read more here: uk.reuters.com
No comments:
Post a Comment